| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000227155.3 |
Lenalidomide |
Bladder urothelial carcinoma |
0.000781016 |
Resistant |
| ENSG00000227155.3 |
Lenalidomide |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042819393 |
Resistant |
| ENSG00000227155.3 |
Lenalidomide |
Esophageal cancer |
0.028723925 |
Resistant |
